Evidence map›Paper›PMID 41669468›Full record

ArticleQuantitative imaging in medicine and surgery2026

Histopathologic basis of a deep learning pelvic computed tomography model for prognostic prediction among patients with advanced high-grade serous ovarian carcinoma.

Rui Yin, Jianming Lin, Jing Huang, Zhaoxiang Dou, Yijun Guo, Pengbo Wang, Yigeng Wang, Xiqi Jian, Lisha Qi, Hong Zhang and 1 more

Abstract read
In one paragraph

Article in Quantitative imaging in medicine and surgery, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Rui Yin *Department of Radiology, Tianjin Chest Hospital, Tianjin, China.
Jianming Lin *Department of Breast Imaging, Tianjin Medical University Cancer Institute and Hospital, National Clinical Research Center for Cancer, Key Laboratory of Cancer Prevention and Therapy, Key Laboratory of Breast Cancer Prevention and Therapy, Tianjin Medical University, Ministry of Education, Tianjin's Clinical Research Center for Cancer, Tianjin, China.
Jing HuangDepartment of Breast Imaging, Tianjin Medical University Cancer Institute and Hospital, National Clinical Research Center for Cancer, Key Laboratory of Cancer Prevention and Therapy, Key Laboratory of Breast Cancer Prevention and Therapy, Tianjin Medical University, Ministry of Education, Tianjin's Clinical Research Center for Cancer, Tianjin, China.
Zhaoxiang DouDepartment of Breast Imaging, Tianjin Medical University Cancer Institute and Hospital, National Clinical Research Center for Cancer, Key Laboratory of Cancer Prevention and Therapy, Key Laboratory of Breast Cancer Prevention and Therapy, Tianjin Medical University, Ministry of Education, Tianjin's Clinical Research Center for Cancer, Tianjin, China.
Yijun GuoDepartment of Breast Imaging, Tianjin Medical University Cancer Institute and Hospital, National Clinical Research Center for Cancer, Key Laboratory of Cancer Prevention and Therapy, Key Laboratory of Breast Cancer Prevention and Therapy, Tianjin Medical University, Ministry of Education, Tianjin's Clinical Research Center for Cancer, Tianjin, China.
Pengbo WangDepartment of Breast Imaging, Tianjin Medical University Cancer Institute and Hospital, National Clinical Research Center for Cancer, Key Laboratory of Cancer Prevention and Therapy, Key Laboratory of Breast Cancer Prevention and Therapy, Tianjin Medical University, Ministry of Education, Tianjin's Clinical Research Center for Cancer, Tianjin, China.
Yigeng WangDepartment of Radiology, National Clinical Research Center for Cancer, Key Laboratory of Cancer Prevention and Therapy, Tianjin's Clinical Research Center for Cancer, Tianjin Medical University Cancer Institute and Hospital, Tianjin, China.
Xiqi JianSchool of Biomedical Engineering & Technology, Tianjin Medical University, Tianjin, China.
Lisha QiDepartment of Pathology, National Clinical Research Center for Cancer, Key Laboratory of Cancer Prevention and Therapy, Tianjin's Clinical Research Center for Cancer, Tianjin Medical University Cancer Institute and Hospital, Tianjin, China.
Hong ZhangDepartment of Radiology, Tianjin Chest Hospital, Tianjin, China.
Wenjuan MaDepartment of Breast Imaging, Tianjin Medical University Cancer Institute and Hospital, National Clinical Research Center for Cancer, Key Laboratory of Cancer Prevention and Therapy, Key Laboratory of Breast Cancer Prevention and Therapy, Tianjin Medical University, Ministry of Education, Tianjin's Clinical Research Center for Cancer, Tianjin, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: A deep learning (DL) model based on preoperative computed tomography (CT) has been proposed for estimating recurrence in patients with ovarian cancer. However, the inherent opacity of DL models complicates the interpretation of their output, limiting their clinical applicability. The aim of this study was thus to generate histopathologic evidence supporting such DL prediction models and to construct a clustering-based analytical framework for identifying patients with risk factors for ovarian cancer. Methods: A retrospective study was conducted in which preoperative CT data were collected from patients with high-grade serous ovarian cancer treated with radical tumor resection from January 2013 to December 2019 at three tertiary care centers. Unsupervised clustering was performed with 1,280 DL model-driven features, and the associations between clusters and histopathological features were analyzed. Multivariate regression was used to investigate the added value of DL outputs for histopathologic correlations. Results: A total of 418 patients [median age 55 years, interquartile range (IQR), 30-77 years] were evaluated. Unsupervised clusters 3 and 4 were associated with the positive status of P53, P16, and Ki-67, along with invasion of the omentum, rectum, and pelvic wall (P<0.05). In the multivariate logistic regression, the DL output, when adjusted for International Federation of Gynecology and Obstetrics (FIGO) stage, was independently associated with P53 [odd ratios (OR) 1.9642; 95% confidence interval (CI): 1.2412-3.1082; P=0.0039], P16 (OR 2.3446; 95% CI: 1.5445-3.5592; P=0.0001), Ki-67 (OR 10.0433; 95% CI: 5.3525-18.8450; P<0.001), invasion of the omentum (OR 2.5995; 95% CI: 1.7175-3.9342; P<0.001), invasion of the rectum (OR 2.3568; 95% CI: 1.5614-3.5574; P<0.001), and pelvic wall effusion (OR 2.0779; 95% CI: 1.3769-3.1360; P=0.0005). Unsupervised cluster 4 and patients with lower principal component analysis (PCA) scores were associated with worse survival (P<0.0001). Conclusions: The DL model could effectively extract histopathological features of high-grade serous ovarian cancer from CT images.

Indexed as

computed tomography (CT)deep learning (DL)high-grade serous ovarian carcinoma (HGSOC)histopathologicInterpretability

Identifiers

PMID41669468
PMCPMC12883471

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.